Logo der DGII
Deutschsprachige Gesellschaft für Intraokularlinsen-Implantation und refraktive Chirurgie
DGII 2010
Homepage

 

Allgemeine Informationen
Über die DGII  
Grußwort  
Allgemeine Hinweise  
für Teilnehmer  
für Vortragende  
Anfahrt  
Rahmenprogramm  
   
Wissenschaftl. Programm
Themen 2010  
Programm  
Raumplan Do, 25.2.  
Raumplan Fr, 26.2.  
Raumplan Sa, 25.2.  
Kurse und Wetlabs  
Pflegepersonal  
Aktive Teilnehmer  
Anschriften  
   
Industrie
Sponsoren  
Aussteller  

 

24. Kongress der DGII 2010

Abstracts DGII 2010

V. Wissenschaftliche Sitzung: Allgemeines/Varia

R34

The Role of the Soemmerring’s Ring in the Pathogenesis of Post-Capsule Opacification
and other Post-Surgical Opacifications

Apple DJ1, Borkenstein AF1, Kleinmann G1, Zuagg B1, Auffarth G2
1 David J. Apple Laboratories for Ophthalmic Devices Research, Sullivan’s Island (USA),
2 Universitäts-Augenklinik Heidelberg

Purpose: In this study we test the hypothesis that the
Soemmerring’s Ring (SR)is the structure of origin of multiple conditions
ranging from simple PCO to capsular phimosis, with many in between.
Methods: We examined the anterior segment structures of eyes that
have had previous cataract surgery with special reference to a
tracing of cells from the region of the peripheral lens to the point
within the eye where they settle. Results: Examination of the capsular
bags of 500 eyes revealed 3 levels of intracapsular LEC activity after
ECCE. Conclusions: The degree of cell proliferation in the capsular
bags was higher than expected. (LECs and SR). To date there are no
surgical means to remove 100% of LECs! A Soemmerring’s Ring, the
precursor of PCO and all other forms of post-surgical fibrosis of
phakic and specialized IOLs occurs in 100% of cases after 5 to 7 years.
All IOL models are susceptible to a breakout of cells from the
Soemmerring’s Ring after ca. 5 – 7 years. Up to 50% of cases have this
breakout.


Erschienen in:
Klin Monatsbl Augenheilkd 2010; 227: Suppl. 1, S1–S24
Georg Thieme Verlag KG Stuttgart · New York · ISSN 1431-634X